Pangaea Selected to Present at the IHF World Hospital Congress
Venue: Lisbon Congress Center, Lisbon, Portugal
Presentation Session: How innovations in early diagnostics and intervention solutions are being implemented into the NHS and improving the efficiency of cancer care in the UK
Learn how NHS clinicians applied Pangaea’s product to find and connect to 6x more undiagnosed and miscoded cachectic cancer patients compared to generic Natural Language Processing (NLP) and ICD approaches. This led to a 50% reduction in treatment costs (from £10,000 to £5,000 per patient), leading to a £1B savings annually in the context of 200,000 such patients in the UK, combined with improved resource allocation and patient outcomes. Whilst also benefitting pharmaceutical sponsors by connecting them to a 6x larger patient pool for their therapies and trials and 6x higher revenues, in a privacy-preserving manner.